Thomas Stephan
Stock Analyst at Stifel
(3.00)
# 1,460
Out of 4,711 analysts
35
Total ratings
45.83%
Success rate
1.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Hold | $65 → $40 | $33.66 | +18.84% | 7 | Dec 20, 2024 | |
| GKOS Glaukos | Maintains: Buy | $145 → $153 | $150.88 | +1.41% | 7 | Dec 2, 2024 | |
| BLCO Bausch + Lomb | Maintains: Hold | $16 → $19 | $18.00 | +5.56% | 2 | Sep 23, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $50 → $44 | $24.82 | +77.28% | 8 | Aug 26, 2024 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.64 | +21.95% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $84.76 | +17.98% | 4 | May 15, 2024 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $7 | $3.57 | +96.08% | 5 | Mar 8, 2024 |
RxSight
Dec 20, 2024
Downgrades: Hold
Price Target: $65 → $40
Current: $33.66
Upside: +18.84%
Glaukos
Dec 2, 2024
Maintains: Buy
Price Target: $145 → $153
Current: $150.88
Upside: +1.41%
Bausch + Lomb
Sep 23, 2024
Maintains: Hold
Price Target: $16 → $19
Current: $18.00
Upside: +5.56%
STAAR Surgical Company
Aug 26, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $24.82
Upside: +77.28%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.64
Upside: +21.95%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $84.76
Upside: +17.98%
Sight Sciences
Mar 8, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $3.57
Upside: +96.08%